Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Response Genetics, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Response Genetics, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Resverlogix Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Resverlogix Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Rexahn Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rexahn Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Reyoung Pharmaceutical Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reyoung Pharmaceutical Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Rigas Farmaceitiska Fabrika Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rigas Farmaceitiska Fabrika Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Rigel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rigel Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

RNL Bio Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RNL Bio Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 73 pages

Roche Holding AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Roche Holding AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Rockwall Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rockwall Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Rohto Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rohto Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Rosetta Genomics, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rosetta Genomics, Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

RPG Life Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RPG Life Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Rubicon Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Rubicon Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

RxElite Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RxElite Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

RXi Pharmaceuticals Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RXi Pharmaceuticals Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

S&P Pharmaceutical Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

S&P Pharmaceutical Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Saamya Biotech (India) Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Saamya Biotech (India) Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Salix Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Salix Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sam Chun Dang Pharmacy Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sam Chun Dang Pharmacy Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sam-A Pharm. Co. Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sam-A Pharm. Co. Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Samaritan Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Samaritan Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Samil Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Samil Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Samjin Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Samjin Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Samsung Pharmaceutical Industry Corporation Limited. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Samsung Pharmaceutical Industry Corporation Limited. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sandu Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sandu Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sangamo Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sangamo Biosciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sangui Biotech International Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sangui Biotech International Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sanguine Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sanguine Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sanitas AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sanitas AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sanjivani Paranteral Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sanjivani Paranteral Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sanochemia Pharmazeutika AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sanochemia Pharmazeutika AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 65 pages

Sanofi Aventis Pakistan Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sanofi Aventis Pakistan Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sanofi Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sanofi Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Santarus Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Santarus Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Santen Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Santen Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Santhera Pharmaceutical Holding Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Santhera Pharmaceutical Holding Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sareum Holdings plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sareum Holdings plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Saudi Pharmaceutical Industries & Medical Appliances Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Saudi Pharmaceutical Industries & Medical Appliances Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Savient Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Savient Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sawai Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sawai Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Scancell Holdings PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Scancell Holdings PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Schnell Biopharmaceuticals,Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Schnell Biopharmaceuticals,Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

SCI Pharmtech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SCI Pharmtech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

SciClone Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SciClone Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

SciGen Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SciGen Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ScinoPharm Taiwan, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ScinoPharm Taiwan, Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

SCOLR Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SCOLR Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

The Searle Company Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

The Searle Company Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Seattle Genetics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Seattle Genetics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Secunderabad Healthcare Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Secunderabad Healthcare Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1